$RGBP Founded in 2012 as a biotechnology company focused on stem cell and immunotherapies for specialty niche treatments. Fully reporting and trades publicly under the symbol: RGBP Focused on immuno-oncology, stem cell/cancer stem cell, gene silencing Currently 2 Investigational New Drug applications (IND) filed with the FDA Three products in preclinical development based on the newly discovered cancer stem cell gene target Picture http://www.regenbiopharmainc.com/uploads/8/7/0/8/8708811/7822216.png http://www.regenbiopharmainc.com/investor-relations.html